Literature DB >> 11217448

Molecular aspects of invasion and metastasis of stomach cancer.

E Tahara1.   

Abstract

The scenario of multiple genetic and epigenetic alterations found in gastric carcinoma differs depending upon the two histological types, indicating that well differentiated or intestinal type and poorly differentiated or diffuse type gastric carcinomas have different genetic pathways. Cancer-stromal interaction through growth factor/cytokine receptor system which plays a central role in invasion and metastasis, is also different between the two types of stomach cancer. The majority of gastric carcinoma exhibit co-expression of IL-8 and its two receptors that evidently confer tumor angiogenesis. IL-8 increases the expression of EGF receptor, VEGF and IL-8 itself by tumor cells themselves, whereas IL-8 decreases expression of E-Cadherin, associated with increase in expression and activity of MMP-9 by tumor cells. These findings overall suggest that IL-8 produced by gastric cancer cells is used for sustained angiogenesis and tissue invasion and metastasis via autocrine/paracrine manners. On the other hand, co-expression of osteopontin (OPN) and CD44v9 in tumor cells correlates well with the degree of lyiphatic vessel invasion or long distant lymph node metastasis in diffuse type gastric carcinoma, indicating that mutual interaction between OPN and CD44v9 on the tumor cells is implicated in lymphogenous metastasis. In addition to these factors, tumor invasion and metastasis requires telomere maintenance regulated by telomerase activity. The human telomerase catalytic subunit, hTERT, is strongly expressed in almost all primary tumors and nodal metastasis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11217448

Source DB:  PubMed          Journal:  Verh Dtsch Ges Pathol        ISSN: 0070-4113


  11 in total

1.  Inhibitory effects of eupatilin on tumor invasion of human gastric cancer MKN-1 cells.

Authors:  Byeong Bae Park; Jin sun Yoon; Eun shil Kim; Jiyoung Choi; Young woong Won; Jung hye Choi; Young Yiul Lee
Journal:  Tumour Biol       Date:  2013-01-08

2.  Altered expression of Krüppel-like factor 4 and β-catenin in human gastric cancer.

Authors:  N Zhang; J Zhang; Z W Wang; L Zha; Z Huang
Journal:  Oncol Lett       Date:  2012-02-28       Impact factor: 2.967

3.  Ets1 as a marker of malignant potential in gastric carcinoma.

Authors:  Yong Yu; Yi-Chu Zhang; Wen-Zhu Zhang; Li-Song Shen; Paul Hertzog; Trevor J Wilson; Da-Kang Xu
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

4.  Prognostic significance of p21WAF1/CIP1, p27Kip1, p53 and E-cadherin expression in gastric cancer.

Authors:  Armando Gamboa-Dominguez; Stefan Seidl; Edgardo Reyes-Gutierrez; Christine Hermannstädter; Leticia Quintanilla-Martinez; Raymonde Busch; Heinz Höfler; Falko Fend; Birgit Luber
Journal:  J Clin Pathol       Date:  2007-05-04       Impact factor: 3.411

5.  Stat3 is involved in angiotensin II-induced expression of MMP2 in gastric cancer cells.

Authors:  Wei Huang; Li-Fen Yu; Jie Zhong; Wei Wu; Jia-Ying Zhu; Feng-Xiang Jiang; Yun-Lin Wu
Journal:  Dig Dis Sci       Date:  2008-12-11       Impact factor: 3.199

6.  Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer.

Authors:  Kayhan Erturk; Didem Tastekin; Murat Serilmez; Elif Bilgin; Hamza Ugur Bozbey; Sezai Vatansever
Journal:  Tumour Biol       Date:  2015-07-29

7.  p75 neurotrophin receptor suppresses the proliferation of human gastric cancer cells.

Authors:  Haifeng Jin; Yanglin Pan; Lina Zhao; Huihong Zhai; Xiaohua Li; Li Sun; Lijie He; Yu Chen; Liu Hong; Yulei Du; Daiming Fan
Journal:  Neoplasia       Date:  2007-06       Impact factor: 5.715

8.  Differential gene expression profiles of gastric cancer cells established from primary tumour and malignant ascites.

Authors:  C Sakakura; A Hagiwara; M Nakanishi; K Shimomura; T Takagi; R Yasuoka; Y Fujita; T Abe; Y Ichikawa; S Takahashi; T Ishikawa; I Nishizuka; T Morita; H Shimada; Y Okazaki; Y Hayashizaki; H Yamagishi
Journal:  Br J Cancer       Date:  2002-11-04       Impact factor: 7.640

9.  Role of peptidylarginine deiminase type 4 in gastric cancer.

Authors:  Jiang Xin; Xiuqi Song
Journal:  Exp Ther Med       Date:  2016-10-11       Impact factor: 2.447

10.  The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.

Authors:  Zhiyi Zhou; Zhouyi Zhou; Jiaming Xie; Ying Cai; Shudong Yang; Ying Chen; HaoRong Wu
Journal:  Diagn Pathol       Date:  2015-07-28       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.